| Literature DB >> 12626540 |
Enza Piccolella1, Francesca Spadaro, Carlo Ramoni, Barbara Marinari, Antonio Costanzo, Massimo Levrero, Lesley Thomson, Robert T Abraham, Loretta Tuosto.
Abstract
We have recently observed that CD28 engagement initiates a signaling pathway leading to the activation of I kappa B kinase (IKK) complex and, consequently, to NF-kappa B activation, and we identified Vav-1 as an important mediator of this function. Here we report for the first time that Vav-1 constitutively associates with IKK alpha in both Jurkat and primary CD4(+) T cells. Vav-1/IKK alpha association is mediated by their helix-loop-helix domains, does not involve IKK beta, and is functionally relevant in that Vav-1-associated IKK alpha kinase activity is increased following CD28 engagement by B7. Moreover, we demonstrate that CD28-induced NF-kappa B activation is augmented by both IKK alpha and Vav-1, but not IKK beta. Confocal microscopy showed that endogenous Vav-1 and IKK alpha, but not IKK beta, were recruited to the membrane and colocalized in response to CD28 stimulation. Taken together, these data evidence that Vav-1 plays a key role in the control of NF-kappa B pathway by targeting IKK alpha in the T cell membrane and favoring its activation in response to CD28 stimulation.Entities:
Mesh:
Substances:
Year: 2003 PMID: 12626540 DOI: 10.4049/jimmunol.170.6.2895
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422